SAMSON MEDCL
GenericsSAMSON MEDCL is a generic drug manufacturer focused on Infectious Disease, Dermatology.
SAMSON MEDCL's Key Drugs
SAMSON MEDCL's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
SAMSON MEDCL's Recent FDA Approvals
New NDA/BLA approvals for SAMSON MEDCL over the last two years — novel drugs only, excluding generics and label supplements.
SAMSON MEDCL's Therapeutic Areas
SAMSON MEDCL's approved drugs and pipeline span 2 therapeutic areas, led by Infectious Disease and Dermatology, across 0 biologic and 0 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
SAMSON MEDCL's Top Competitors
SAMSON MEDCL's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Baxter, and B BRAUN. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
SAMSON MEDCL Pipeline Snapshot
Active clinical trials for SAMSON MEDCL across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Infectious Disease pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2006-11-29
- Latest
- 2022-01-13
- Applications
- 6